Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single-center, Double-blind, Placebo-controlled, Phase 3 Trial
静脉注射托珠单抗与标准疗法治疗重症和危重症 COVID-19 相关肺炎:一项单中心、双盲、安慰剂对照的 3 期试验
期刊:
影响因子:
doi:10.47895/amp.vi0.6175
Amante, Eric Jason B; David-Wang, Aileen S; Tee, Michael L; Punzalan, Felix Eduardo R; Añonuevo, John C; Fernandez, Lenora C; Albay, Albert B Jr; Malabad, John Carlo M; Climacosa, Fresthel Monica M; Pajes, A Nico Nahar I; Cuaño, Patricia Maria Gregoria M; Alejandría, Marissa M